Defence groups strike $8bn of maritime tech deals - FT中文网
登录×
电子邮件/用户名
密码
记住我
请输入邮箱和密码进行绑定操作:
请输入手机号码,通过短信验证(目前仅支持中国大陆地区的手机号):
请您阅读我们的用户注册协议隐私权保护政策,点击下方按钮即视为您接受。
商业快报

Defence groups strike $8bn of maritime tech deals

Tie-up comes amid surge of interest in defence technology, as Thales unveils planned purchase of French naval drone maker
00:00

{"text":[[{"start":8.85,"text":"Defence groups Lockheed Martin and Thales struck twin maritime technology deals worth close to $8bn on Monday, as heightened tensions around global waterways drive a surge of interest."}],[{"start":20.049999999999997,"text":"Lockheed has agreed a $3.45bn deal to acquire naval technology group Ultra Maritime from private equity firm Advent, while Thales unveiled a transaction for Paris-listed Exail Technologies, which values the maritime robotics and navigation company at €3.9bn."}],[{"start":38.599999999999994,"text":"The pair of deals illustrates the increasing growth potential of maritime security and warfare to defence companies. Countries and the Nato alliance have come to see protecting undersea energy and communications infrastructure as a priority."}],[{"start":53.449999999999996,"text":"Maryland-based Lockheed, one of the US’s largest aerospace and defence groups with a market capitalisation of about $125bn, saw off rivals for Ultra Maritime including Thales, people familiar with the matter said. Thales declined to comment. "}],[{"start":68.85,"text":"That deal gives Lockheed ownership of Ultra Maritime’s sensitive technology for undersea warfare, where it is a world leader in technology for detecting submarines and torpedoes."}],[{"start":80.55,"text":"Ultra Maritime is a division of Advent’s Cobham Ultra business, which the private equity group built up through the acquisitions of British defence group Cobham for £4bn in 2019 and its £2.6bn deal for Ultra Electronics, which came two years later."}],[{"start":99,"text":"Advent said it had invested $170mn into the company’s product development and manufacturing over the past three years, with revenues rising 17 per cent annually over that timeframe. "}],[{"start":111.85,"text":"Ultra Maritime’s revenue was on track to jump to about $784mn in 2026 from $494mn in 2023, the FT previously reported."}],[{"start":122.8,"text":"“When we invested in Ultra Maritime in 2022, we saw a business with mission-critical technology and a vital role in protecting allied nations from undersea threats, but one that had been underinvested,” said Advent managing partner Shonnel Malani. “Over the past four years, we have changed that.”"}],[{"start":142,"text":"Thales meanwhile secured a deal for the Gorgé family’s 35.5 per cent stake in Exail, and announced a tender offer for the rest of the company."}],[{"start":152.4,"text":"Adding Exail will allow Thales to expand into demining operations, the importance of which has been underlined by Iranian operations in the Strait of Hormuz. Jet engine maker Safran had said just days ago that it was in exclusive talks to buy the Exail stake.  "}],[{"start":168.6,"text":"Thales trumpeted the strategic value of the deal for improving Europe’s technological independence from the US and said the acquisition would add to revenue and operating income by 2032."}],[{"start":180.4,"text":"“We will strengthen our high-technology industrial base and innovation for our world-class defence and civil customers, while reinforcing Europe’s technological sovereignty,” Thales CEO Patrice Caine said."}],[{"start":192.75,"text":"This article has been updated to remove a reference to the movement in Exail’s share price"}],[{"start":206.9,"text":""}]],"url":"https://audio.ftcn.net.cn/album/a_1783399100_1500.mp3"}

版权声明:本文版权归FT中文网所有,未经允许任何单位或个人不得转载,复制或以任何其他方式使用本文全部或部分,侵权必究。

谷歌为Anthropic打造的2000亿美元华尔街融资机器

私募信贷、芯片租赁和数据中心担保,支撑起AI支出的全新庞大模式。

“日元干预”等于“美国自保”

美国联手日本支撑日元,不只是出于盟友情谊,更是为了避免日本加息或美国国债遭抛售、导致美债收益率进一步走高。

“诅咒之岛”:科技游民与诈骗犯藏身的千亿美元奢华开发项目

警方的突击搜查再次打击了马来西亚陷入困境的中资“森林城市”项目的声誉。

问题不在因凡蒂诺

马杜罗:应该将国际足联的监管职能与商业活动分开,其治理应真正做到包容并具有代表性,监督必须真正独立。

俄罗斯扩大“影子”液化天然气船队,应对欧盟禁令

随着明年制裁进一步收紧,越来越多的“影子”船舶将帮助俄罗斯继续出口液化天然气。

阿斯利康与百时美施贵宝:大药企有时也不够大

当资产负债表规模扩大、能够押注潜在重磅药物时,规模才会带来优势。
设置字号×
最小
较小
默认
较大
最大
分享×